Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Gamelin

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
Clinical Pharmacology and Therapeutics|July 20, 2007
Chronopharmacokinetics of oral tegafur and uracil in colorectal cancer patientsM-C Etienne-Grimaldi, J-M Cardot, E François, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 1998
Plasma sialic acid as a marker of the effect of the treatment on metastatic colorectal cancerT Painbeni, E Gamelin, A Cailleux, et al.
British Journal of Haematology|December 1, 1995
Peripheral primitive neuroectodermal tumour after allogeneic bone marrow transplantationE Gamelin, S François, S Guyetant, et al.
Cancer|May 1, 1992
Non-Hodgkin's lymphoma presenting with primary adrenal insufficiency. A disease with an underestimated frequency?E Gamelin, V Beldent, M C Rousselet, et al.
Bulletin Du Cancer|January 1, 1987
Computed tomography in radiotherapy of prostatic carcinomaY M Allain, B Dixon, P Cellier, et al.
Blood|May 15, 1997
Expression of the multidrug resistance-associated protein gene in refractory lymphoma: quantitation by a validated polymerase chain reaction assayZ Zhan, V A Sandor, E Gamelin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 8, 1998
Suppression of heparinization of central venous catheters between cycles of chemotherapy. Results of a phase I studyR Delva, E Gamelin, A Lortholary, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Correlation between uracil and dihydrouracil plasma ratio, fluorouracil (5-FU) pharmacokinetic parameters, and tolerance in patients with advanced colorectal cancer: A potential interest for predicting 5-FU toxicity and determining optimal 5-FU dosageE Gamelin, M Boisdron-Celle, V Guérin-Meyer, et al.
Bulletin Du Cancer|January 1, 1991
[Acute cardiac toxicity of 5-fluorouracil: pharmacokinetic correlation]E Gamelin, L Gamelin, F Larra, et al.
Bulletin Du Cancer|January 7, 2005
A phase I-II, dose-escalating trial of ZD9331 in combination with irinotecan (CPT11) in previously pretreated metastatic colorectal cancer patientsC Louvet, T André, E Gamelin, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Clinical Pharmacology and Therapeutics|July 20, 2007
Chronopharmacokinetics of oral tegafur and uracil in colorectal cancer patientsM-C Etienne-Grimaldi, J-M Cardot, E François, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 1998
Plasma sialic acid as a marker of the effect of the treatment on metastatic colorectal cancerT Painbeni, E Gamelin, A Cailleux, et al.
British Journal of Haematology|December 1, 1995
Peripheral primitive neuroectodermal tumour after allogeneic bone marrow transplantationE Gamelin, S François, S Guyetant, et al.
Cancer|May 1, 1992
Non-Hodgkin's lymphoma presenting with primary adrenal insufficiency. A disease with an underestimated frequency?E Gamelin, V Beldent, M C Rousselet, et al.
Bulletin Du Cancer|January 1, 1987
Computed tomography in radiotherapy of prostatic carcinomaY M Allain, B Dixon, P Cellier, et al.
Blood|May 15, 1997
Expression of the multidrug resistance-associated protein gene in refractory lymphoma: quantitation by a validated polymerase chain reaction assayZ Zhan, V A Sandor, E Gamelin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 8, 1998
Suppression of heparinization of central venous catheters between cycles of chemotherapy. Results of a phase I studyR Delva, E Gamelin, A Lortholary, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Correlation between uracil and dihydrouracil plasma ratio, fluorouracil (5-FU) pharmacokinetic parameters, and tolerance in patients with advanced colorectal cancer: A potential interest for predicting 5-FU toxicity and determining optimal 5-FU dosageE Gamelin, M Boisdron-Celle, V Guérin-Meyer, et al.
Bulletin Du Cancer|January 1, 1991
[Acute cardiac toxicity of 5-fluorouracil: pharmacokinetic correlation]E Gamelin, L Gamelin, F Larra, et al.
Bulletin Du Cancer|January 7, 2005
A phase I-II, dose-escalating trial of ZD9331 in combination with irinotecan (CPT11) in previously pretreated metastatic colorectal cancer patientsC Louvet, T André, E Gamelin, et al.
Pageof 8